Enrique Poradosu serves as Executive at Nuvectis Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Enrique Poradosu has executed 10 insider transactions totaling $35.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 6, 2026 involved receiving (via award) 150,000 shares valued at $0.
Enrique Poradosu currently holds 1,806,319 shares of Nuvectis Pharma, Inc. (NVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Enrique Poradosu has been a net buyer of NVCT stock. They have purchased $35.0K and sold $0 worth of shares.
Enrique Poradosu's most recent insider trade was on Jan 6, 2026, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.29 |
| Discretionary |
| Jan 3, 2024 | NVCT | $0 | Award | 130,000 | $N/A | Discretionary |
| Mar 27, 2023 | NVCT | $5.8K | Purchase | 500 | $11.55 | Discretionary |
| Jan 12, 2023 | NVCT | $0 | Award | 115,000 | $N/A | Discretionary |
| May 12, 2022 | NVCT | $5.5K | Purchase | 370 | $14.76 | Discretionary |
| May 12, 2022 | NVCT | $4.8K | Purchase | 300 | $16.04 | Discretionary |
| Apr 1, 2022 | NVCT | $0 | Award | 60,000 | $N/A | Discretionary |
| Feb 7, 2022 | NVCT | $3.1K | Purchase | 800 | $3.88 | Discretionary |
| Feb 4, 2022 | NVCT | $12.7K | Purchase | 3,800 | $3.35 | Discretionary |